NAPROXEN TABLETS USP, 500 mg, 100-count Tablets per bottle, Rx only, Manufactured by: Glenmark Generics Ltd., Colvale-Bardez, Goa 403513, India; Manufactured for: Glenmark Generics Inc., USA, Mahwah, NJ 07430; NDC 68462-190-01.
Published October 3, 2012 · Recall initiated: July 6, 2012
Summary
FDA records drug Class II recall D-1701-2012, published October 3, 2012 and initiated July 6, 2012. Recalling firm: Glenmark Generics Inc., USA; Status: Terminated; Reported quantity: unknown; Lot: Lot #: 02112930, 02112934, 02112941, Exp 09/14; 2112985, 02112986, 02113334, Exp 10/14; 02113360, 02113372, 02113420, 02113606, 02113663, 02113664, Exp 11/14. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Label Mix-Up: Bottles labeled as Naproxen Tablets USP, 500 mg, 100-count may contain 90-count Pravastatin Sodium Tablets, 40 mg.
What to do
Voluntary: Firm initiated · Letter
Get an email if NAPROXEN SODIUM has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- NAPROXEN SODIUM
- Manufacturer
- Glenmark Generics Inc., USA
- Distributor
- Nationwide
- UPC
- 0368462189016
- Lot
- Lot #: 02112930, 02112934, 02112941, Exp 09/14; 2112985, 02112986, 02113334, Exp 10/14; 02113360, 02113372, 02113420, 02113606, 02113663, 02113664, Exp 11/14.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDANaproxen Sodium Tablets, USP, 550mg, 100-count bottles, Rx Only, Manufactured by: Glenmark PharmaceuticalsApril 16, 2025
- FDANaproxen Tablets, USP 250mg, 100-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd.December 6, 2023
- FDAJapan Weight Loss Blue Capsules, 9 g (300 mg), 30 count box, Green algae lipotropic (fat dissolving) agent,October 3, 2012
- FDALevetiracetam Tablets, USP 500 mg, 500 count bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc.October 3, 2012
- FDAMan King Capsules, 2800 mg, boxes of 5 packets, OTC, Developed by: American Wanbao PharmaceuticalOctober 3, 2012
- FDAWhey Protein Concentrate, Net Weight: 1lb (454g)October 3, 2012
Questions about this recall
Was NAPROXEN TABLETS USP, 500 mg, 100-count Tablets per bottle, Rx only, Manufactured by: Glenmark Generics Ltd., Colvale-Bardez, Goa 403513, India; Manufactured for: Glenmark Generics Inc., USA, Mahwah, NJ 07430; NDC 68462-190-01. recalled?
Yes. FDA published recall D-1701-2012 on October 3, 2012. Reported hazard: Labeling: Label Mix-Up: Bottles labeled as Naproxen Tablets USP, 500 mg, 100-count may contain 90-count Pravastatin Sodium Tablets, 40 mg.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: NAPROXEN SODIUM. UPC: 0368462189016.